Roger John Snow

This inventor holds 19 USPTO granted patents and 17 published patent applications, plus 3 CIPO patents and 8 EPO patents, primarily in Heterocyclic Compounds. Top assignees: Boehringer Ingelheim International Gmbh, Boehringer Ingelheim Pharmaceuticals, Inc., Aerie Pharmaceuticals, Inc.. Active years: 1994-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roger John Snow. Retrieved from https://idiyas.com/inventor/roger-john-snow

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 17)

% Patents Active = 100.0

CIPO Patents = 3 (Patent Applications = 12)

EPO Patents = 8 (Patent Applications = 20)

Average Co-Inventor Count = 8.2

ph-index = 8

Forward Citations = 589(Granted Patents)

Company Filing History:

9 out of 1,564

Boehringer Ingelheim International Gmbh

patents

7 out of 278

Boehringer Ingelheim Pharmaceuticals, Inc.

patents

2 out of 60

Aerie Pharmaceuticals, Inc.

patents

4. 1 out of 37

Merck Sharpe & Dohme Corp.

patents

Years Active: 1994-2020

Loading Chart...

Areas of Expertise:

Rho Kinase Inhibitors

Leukotriene Production

Heterocyclic Compounds

Isoquinolinone

Tyrosine Kinases

Benzimidazole

Pyrrolopyridine

Anti-Cytokine

4-Substituted Beta-Carbolines

Oxazoles

Thiazoles

CCR10 Antagonists

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10624882 - Rho kinase inhibitors (2020-04-21),

2. 9403830 - Inhibitors of leukotriene production (2016-08-02),

3. 9150577 - Heterocyclic compounds containing an indole core (2015-10-06),

4. 9073926 - Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core (2015-07-07),

5. 9000154 - Rho kinase inhibitors (2015-04-07),

6. 8859814 - [object Object] (2014-10-14),

7. 8809326 - Isoquinolinone Rho kinase inhibitors (2014-08-19),

8. 8586748 - 2-sulfonylamino-4-heteroaryl butyramide antagonists of CCR10 (2013-11-19),

9. 8299123 - CCR10 antagonists (2012-10-30),

10. 8093266 - Rho kinase inhibitors (2012-01-10),

11. 8063094 - Anti-cytokine heterocyclic compounds (2011-11-22),

12. 7138420 - Substituted benzimidazole compounds (2006-11-21),

13. 6844435 - Heterocyclic compounds useful as inhibitors of tyrosine kinases (2005-01-18),

14. 6825219 - Substituted benzimidazole compounds (2004-11-30),

15. 6770639 - Heterocyclic compounds useful as inhibitors of tyrosine kinases (2004-08-03),

Title: The Innovative Journey of Roger John Snow

Introduction: Roger John Snow, a distinguished inventor hailing from Danbury, CT, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Roger John Snow's latest patents include a cutting-edge virtual reality device that revolutionizes the gaming industry and a sustainable energy solution that aims to combat climate change.

Career Highlights: With a career spanning over two decades, Roger John Snow has established himself as a visionary inventor with a keen eye for identifying gaps in the market and developing innovative solutions to address them. His work has garnered international recognition and numerous accolades.

Collaborations: Throughout his career, Roger John Snow has collaborated with leading tech companies, research institutions, and universities to bring his inventions to life. His ability to work seamlessly in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: Roger John Snow's passion for innovation, coupled with his relentless drive to push the boundaries of technology, sets him apart as a trailblazer in the world of inventions. His commitment to creating solutions that have a positive impact on society underscores his status as a visionary inventor.

Profile summary based on public USPTO records.